Found: 9
Select item for more details and to access through your institution.
Multi-target measurable residual disease assessed by error-corrected sequencing in patients with acute myeloid leukemia: An ALFA study.
- Published in:
- Blood Cancer Journal, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41408-024-01078-8
- By:
- Publication type:
- Article
Biomarkers of Gemtuzumab Ozogamicin Response for Acute Myeloid Leukemia Treatment.
- Published in:
- International Journal of Molecular Sciences, 2020, v. 21, n. 16, p. 5626, doi. 10.3390/ijms21165626
- By:
- Publication type:
- Article
A review of lesbian, gay, bisexual, trans and intersex (LGBTI) health and healthcare inequalities.
- Published in:
- European Journal of Public Health, 2019, v. 29, n. 5, p. 974, doi. 10.1093/eurpub/cky226
- By:
- Publication type:
- Article
Hémophilie A acquise, le traitement par emicizumab peut relayer les agents by-passants : à propos de deux cas et une revue de la littérature.
- Published in:
- Annales de Biologie Clinique, 2024, v. 82, n. 3, p. 294, doi. 10.1684/abc.2024.1900
- By:
- Publication type:
- Article
Bactériémie à Erysipelothrix rhusiopathiae : un diagnostic pas si facile !
- Published in:
- Annales de Biologie Clinique, 2016, v. 74, n. 5, p. 613, doi. 10.1684/abc.2016.1183
- By:
- Publication type:
- Article
PPARγ agonists promote the resolution of myelofibrosis in preclinical models.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Assessment of global longitudinal strain at low-dose anthracycline-based chemotherapy, for the prediction of subsequent cardiotoxicity.
- Published in:
- European Heart Journal - Cardiovascular Imaging, 2017, v. 18, n. 4, p. 392, doi. 10.1093/ehjci/jew223
- By:
- Publication type:
- Article
USO DE CLAR EN FASE INVERSA PARA LA DETERMINACIÓN DEL CONTENIDO DE FORMALDEHÍDO LIBRE EN ESMALTES DE UÑAS.
- Published in:
- Ingeniería Solidaria, 2017, v. 13, n. 22, p. 29, doi. 10.16925/in.v13i22.1750
- By:
- Publication type:
- Article
Un cas de syndrome 8p11 associé à une leucémie aiguë érythroblastique et à un lymphome lymphoblastique T traité par l'association ponatinib et chimiothérapie.
- Published in:
- Hematologie, 2017, v. 23, n. 2, p. 135, doi. 10.1684/hma.2017.1248
- By:
- Publication type:
- Article